Search the Newsreel

Armistice Capital (OFIX) discloses 3.26M-share, 8.01% Orthofix Medical stake

Armistice Capital, LLC and Steven Boyd have reported an updated beneficial ownership stake of 8.01% in Orthofix Medical Inc., totaling 3,264,000 shares. This disclosure, made via an Amendment No. 8 to their Schedule 13G, indicates shared voting and dispositive power over these shares, which …

Orthofix Medical Earnings Call Signals Cautious Turnaround

CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Cuts Target Price to $13

CCORF has reiterated its Buy rating for Orthofix Medical (OFIX.US) but has lowered its target price to $13. This indicates a continued positive outlook on the company despite a revised valuation.

Dimensional Fund Advisors LP Trims Stock Holdings in Orthofix Medical Inc. $OFIX

Dimensional Fund Advisors LP reduced its stake in Orthofix Medical Inc. (NASDAQ:OFIX) by 11.3% in the first quarter, selling 107,566 shares but retaining 841,521 shares valued at approximately $9.65 million. Despite institutional investors owning nearly 90% of the stock, Orthofix Medical continues to face …

Orthofix Medical Inc. (OFIX): Analyzing the 34.43% Potential Upside in the Medical Devices Sector

Orthofix Medical Inc. (NASDAQ: OFIX) is a medical devices company with a projected 34.43% potential upside, according to analyst consensus. Despite financial challenges like negative EPS and ROE, the company is seen as undergoing a transformation with strategic investments in product development, particularly in …

Orthofix Medical (OFIX) Stock Sinks As One Off Growth Clouds Outlook

Orthofix Medical's stock dropped 15% despite management raising full-year revenue and adjusted EBITDA guidance. While the company showed progress in profitability and growth in specific product areas, concerns remain regarding the quality and concentration of its revenue, including a one-off European distributor purchase that …

Earnings call transcript: Orthofix tops Q2 2026 estimates, lifts outlook

Orthofix (OFIX) reported Q2 2026 results that surpassed analyst estimates, driven by improving sales trends and the restoration of Medicare reimbursement. The medical-device maker also raised its full-year sales and adjusted EBITDA guidance. Despite ongoing challenges with smaller U.S. spine distributors, the company highlighted …

Orthofix Medical Releases Q2 2026 Financial Results

Orthofix Medical Inc. (OFIX) reported Q2 2026 financial results, showing a diluted loss of $0.39 per share, significantly wider than the anticipated $0.03 loss. Despite the earnings shortfall with a net loss of $15.8M, the company's revenue reached $210.9M, surpassing estimates by 0.8% and …

Orthofix Medical (NASDAQ:OFIX) Issues Quarterly Earnings Results

Orthofix Medical Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:OFIX) 2026-08-05

Orthofix Medical Inc. (OFIX) released its Q2 2026 earnings call presentation on August 5, 2026. The company reported an EPS of $0.07, beating estimates by $0.10, and revenue of $210.93M, which was a 3.85% year-over-year increase and beat estimates by $1.66M. The presentation provides …

Orthofix Medical Inc. Q2 2026: Revenue $210.9M, EPS $(0.39) — 10-Q Summary

[10-Q] Orthofix Medical Inc. Quarterly Earnings Report

Medicare reimbursement restored as Orthofix raises its 2026 outlook

Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates

(OFIX) Movement as an Input in Quant Signal Sets

This article analyzes Orthofix Medical Inc. (NASDAQ: OFIX) using quantitative research, highlighting a potential short setup with an exceptional risk-reward ratio. It details various institutional trading strategies (Position, Momentum Breakout, Risk Hedging) and provides a multi-timeframe signal analysis, showing divergent sentiment across near, mid, …

Orthofix Number of Employees 2026 | Employee Count & Headcount Data

Orthofix, Inc. had approximately 1,287 employees worldwide as of March 2026, marking a 9.9% growth since 2023 but a 0.4% year-over-year decrease from 2025. The company, headquartered in McKinney, Texas, is actively hiring with 84 active job postings in 2026 and an average employee …

Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for

Analysts expect Orthofix (OFIX) to report a year-over-year decline in earnings for the quarter ended June 2026, despite anticipating higher revenues. The company is projected to post a quarterly loss of $0.03 per share on revenues of $209.51 million. While the stock currently holds …

Orthofix Medical (OFIX) Projected to Post Earnings on Wednesday

Orthofix Medical Inc (OFIX) Institutional Confidence

The article analyzes the institutional confidence in Orthofix Medical Inc (OFIX), highlighting its strong position in the Healthcare Equipment & Supplies industry. With an institutional shareholding score of 10.00, OFIX ranks highly, and its institutional shareholding proportion has increased by 4.24% quarter-over-quarter. Key institutional …

OFIX|Orthofix Medical Inc|Price:11.770|Chg%:-0.020

This article provides a comprehensive stock analysis of Orthofix Medical Inc (OFIX), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. It notes strong institutional ownership, a "Buy" rating from multiple analysts with a target …

Orthofix Medical Inc. Revenue Breakdown – NASDAQ:OFIX

Orthofix Medical Inc. (NASDAQ: OFIX) generated $822.31 million USD in revenue last year. Its top-performing segment, Global Spine, contributed $687.65 million USD, an increase from the previous year. The United States was the largest geographical contributor, accounting for $684.07 million USD of the total …

Orthofix Medical Inc (OFIX) Cash Flow

This article provides a comprehensive financial overview of Orthofix Medical Inc (OFIX), focusing on its cash flow statements. It details quarterly and annual data for operating, investing, and financing cash flows, including specific figures for net income, capital expenditures, and debt activities. The report …

Can Orthofix Medical (NASDAQ:OFIX) Capitalize on A Key Medicare Shift?

Orthofix Medical (NASDAQ:OFIX) is back in focus following a Medicare policy reversal regarding the classification of non-invasive bone growth stimulators. This shift is significant for the small-cap spine and orthopedics maker, particularly for its bone growth therapies which are a key product line within …

Orthofix Medical Inc (OFIX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Orthofix Medical Inc (OFIX), listing its major shareholders and their respective proportions. It also breaks down shareholder types and provides institutional shareholding data over several quarters. Key shareholders include Engine Capital Management, LP and Juniper Investment Company, …

Orthofix Medical Inc (OFIX) Financial Health: Profitability & Balance Sheet Analysis

Orthofix Medical Inc (OFIX) has a stable financial status with high operating efficiency, reflected in its current financial score of 7.44, ranking 83rd in its industry. The company reported a 1.58% year-over-year increase in quarterly revenue to $196.71M and a substantial 60.62% increase in …

Orthofix Medical Inc. (OFIX) stock price, news, quote and history

This article provides a comprehensive overview of Orthofix Medical Inc. (OFIX) stock, including its current price, historical data, and key financial metrics. It details the company's operations across its Global Spine and Global Limb Reconstruction segments, highlighting its medical device offerings and market presence. …

OFIX|Orthofix Medical Inc|Price:11.260|Chg%:+0.300

Orthofix Medical Inc. (OFIX) is a global medical technology company specializing in spinal hardware, bone growth therapies, and orthopedic solutions. The company's stock currently trades at $11.260, up 2.74%. Its Global Spine segment is the primary revenue driver, generating $440.49M in Q1 2026, accounting …

Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement

Rewey Asset Management highlighted Orthofix Medical Inc. (OFIX) in its Q2 2026 investor letter, noting its attractiveness after the CMS completely reversed a prior reimbursement code change. Despite an earlier setback that led to reduced revenue guidance, the firm views this reversal as a …

Orthofix Medical (OFIX) Shows Strength: Approaches Resistance Near $11.83 After 2.92% Gain - Pre-Earnings Momentum

Orthofix will host an 8:30 a.m. call to review Q2 results

Orthofix Medical (OFIX) Receives a Buy from Barrington

Orthofix Medical (OFIX) Soars 16% Following CMS Reversal on Bone Growth Stimulators

Orthofix Medical (OFIX) Among the Best Small-Cap Growth Stocks To Buy Now